Metraipolis › archive › dc_2104e1dce180

Cardiological aspects of Fabry disease: from diagnosis to therapeutic efficacy assessment — Europe PMC PMID:42426782

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42426782
DOI
10.1186/s13023-[numero omesso]-1
License (as archived)
solo-consultazione
Archived
2026-10-18T09:17:30.455Z
SHA-256 of the archived text
6cefc9c2dcdbae0422763ee4b690a5ac01657eaa83c86ce552d522d6cdd532c9
Stable URL of this page
https://metraipolis.com/documento/dc_2104e1dce180

How to cite

Cardiological aspects of Fabry disease: from diagnosis to therapeutic efficacy assessment — Europe PMC PMID:42426782 — Europe PMC (en), https://europepmc.org/article/MED/42426782 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_2104e1dce180 (Metraipolis archive dc_2104e1dce180, sha256 6cefc9c2dcdbae0422763ee4b690a5ac01657eaa83c86ce552d522d6cdd532c9)
BibTeX
@misc{dc2104e1dce180,
  title = {Cardiological aspects of Fabry disease: from diagnosis to therapeutic efficacy assessment — Europe PMC PMID:42426782},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42426782},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_2104e1dce180; sha256 6cefc9c2dcdbae0422763ee4b690a5ac01657eaa83c86ce552d522d6cdd532c9},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42426782. Agents can read the archived copy with the MCP tool read_document.